ASX - By Stock
|
RAP |
Re:
Terrible Tadpole just sold half his shares
|
|
Cosmoclarke
|
66 |
17K |
0 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
66
|
17K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Terrible Tadpole just sold half his shares
|
|
Cosmoclarke
|
66 |
17K |
7 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
66
|
17K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
Cosmoclarke
|
62 |
17K |
7 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
62
|
17K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
What to expect if Pfizer's takeover fails
|
|
Cosmoclarke
|
108 |
23K |
3 |
27/07/22 |
27/07/22 |
ASX - By Stock
|
108
|
23K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Cosmoclarke
|
446 |
98K |
11 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
446
|
98K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Cosmoclarke
|
466 |
160K |
20 |
26/07/22 |
26/07/22 |
ASX - By Stock
|
466
|
160K
|
20
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Cosmoclarke
|
446 |
98K |
10 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
446
|
98K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Cosmoclarke
|
466 |
160K |
5 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
466
|
160K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Cosmoclarke
|
446 |
98K |
2 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
446
|
98K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Cosmoclarke
|
446 |
98K |
29 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
446
|
98K
|
29
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Cosmoclarke
|
446 |
98K |
6 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
446
|
98K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Cosmoclarke
|
446 |
98K |
1 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
446
|
98K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Cosmoclarke
|
446 |
98K |
6 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
446
|
98K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Cosmoclarke
|
446 |
98K |
3 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
446
|
98K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Clarification - Scheme Booklet registered with ASIC
|
|
Cosmoclarke
|
29 |
8.2K |
3 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
29
|
8.2K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Booklet registered with ASIC
|
|
Cosmoclarke
|
151 |
45K |
16 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
151
|
45K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
Top-up fundraiser
|
|
Cosmoclarke
|
446 |
98K |
8 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
446
|
98K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Computershare Calling - Pfizer feedback
|
|
Cosmoclarke
|
96 |
34K |
0 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
96
|
34K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Computershare Calling - Pfizer feedback
|
|
Cosmoclarke
|
96 |
34K |
1 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
96
|
34K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
Cosmoclarke
|
151 |
50K |
16 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
151
|
50K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate Licence Agreement Clarification Announcement
|
|
Cosmoclarke
|
34 |
12K |
21 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
34
|
12K
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
Cosmoclarke
|
151 |
50K |
23 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
151
|
50K
|
23
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
Cosmoclarke
|
151 |
50K |
8 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
151
|
50K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
Cosmoclarke
|
126 |
37K |
6 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
37K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
|
|
Cosmoclarke
|
126 |
37K |
12 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
126
|
37K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Cough detection patent granted in Australia and Japan
|
|
Cosmoclarke
|
47 |
14K |
17 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
47
|
14K
|
17
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
Cosmoclarke
|
132 |
46K |
8 |
03/07/22 |
03/07/22 |
ASX - By Stock
|
132
|
46K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
Cosmoclarke
|
132 |
46K |
8 |
03/07/22 |
03/07/22 |
ASX - By Stock
|
132
|
46K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
Cosmoclarke
|
132 |
46K |
7 |
02/07/22 |
02/07/22 |
ASX - By Stock
|
132
|
46K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
Cosmoclarke
|
132 |
46K |
19 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
132
|
46K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
Cosmoclarke
|
132 |
46K |
12 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
132
|
46K
|
12
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
Cosmoclarke
|
93 |
31K |
15 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
93
|
31K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
4 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
Cosmoclarke
|
93 |
31K |
1 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
93
|
31K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
Cosmoclarke
|
93 |
31K |
1 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
93
|
31K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
Cosmoclarke
|
93 |
31K |
0 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
93
|
31K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
Cosmoclarke
|
93 |
31K |
3 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
93
|
31K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
Cosmoclarke
|
93 |
31K |
3 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
93
|
31K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
Cosmoclarke
|
93 |
31K |
7 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
93
|
31K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
Cosmoclarke
|
377 |
142K |
1 |
24/06/22 |
24/06/22 |
ASX - By Stock
|
377
|
142K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Cosmoclarke
|
425 |
125K |
1 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
425
|
125K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
Cosmoclarke
|
93 |
31K |
15 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
93
|
31K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Cosmoclarke
|
425 |
125K |
23 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
425
|
125K
|
23
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Cosmoclarke
|
425 |
125K |
4 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
125K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Cosmoclarke
|
425 |
125K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
125K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Cosmoclarke
|
425 |
125K |
27 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
125K
|
27
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Cosmoclarke
|
3.3K |
2.5M |
14 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Cosmoclarke
|
425 |
125K |
7 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
125K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Cosmoclarke
|
425 |
125K |
0 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
125K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Proposed EGM and VOTE THEM OUT
|
|
Cosmoclarke
|
12 |
3.4K |
2 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
12
|
3.4K
|
2
|
|